588 results on '"Rydén, Lisa"'
Search Results
2. Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study
3. Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
4. Quality assessment of radiotherapy in the prospective randomized SENOMAC trial
5. Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750)
6. Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer: A Swedish retrospective cohort study
7. Monitoring ctDNA dynamics in early breast cancer using a novel ultra-sensitive tumor-informed structural variant approach combining whole-genome sequencing and multiplex dPCR.
8. Into the twilight zone – should ER-low breast cancer be treated as triple negative breast cancer?
9. Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study
10. The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
11. Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy
12. Gene expression in metastatic breast cancer—patterns in primary tumors and metastatic tissue with prognostic potential
13. PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
14. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
15. Health-related quality of life by type of breast surgery in women with primary breast cancer: prospective longitudinal cohort study.
16. Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
17. Quality Assessment of Radiotherapy in the Prospective Randomized Senomac Trial
18. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis
19. Gene expression in metastatic breast cancer – patterns with prognostic potential in primary tumors and metastatic tissue
20. Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning: External Validation and Further Model Development
21. Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
22. Prediction of Tamoxifen Benefit in Premenopausal Breast Cancer Patients Evaluated by Three Methods for Determination of Hormone Receptor Status
23. Breast Cancer Diagnosis Using Extended-Wavelength–Diffuse Reflectance Spectroscopy (EW-DRS)—Proof of Concept in Ex Vivo Breast Specimens Using Machine Learning
24. Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
25. Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
26. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
27. Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment
28. Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer - data from the randomized SBII:2 trial
29. Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy
30. Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
31. Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
32. Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up
33. The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
34. Supplementary Information and Table 1 from Classification of Breast Cancer Using Genetic Algorithms and Tissue Microarrays
35. Figure S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort
36. Supplementary Table 1 from CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation Resistance
37. Supplementary Data from Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer
38. Appendix S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort
39. Retrospective Validation Study of an Artificial Neural Network-Based Preoperative Decision-Support Tool for Noninvasive Lymph Node Staging (NILS) in Women with Primary Breast Cancer (ISRCTN14341750)
40. Abstract P1-09-06: Save the breast after neoadjuvant therapy – identifying radiological and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy
41. Abstract P5-01-08: Steps toward noninvasive lymph node staging (NILS) in clinically node negative patients: Artificial neural network model to preoperatively predict lymphovascular invasion
42. The implementation of NILS: A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
43. A preoperative prediction model for sentinel lymph node status using artificial intelligence on mammographic images and clinicopathological variables in patients with clinically node-negative breast cancer
44. Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning: External Validation and Further Model Development (Preprint)
45. Psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) in a non-clinical population in Sweden
46. Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer
47. Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
48. The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
49. Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker Discovery
50. Aromatase inhibitors alone or sequentially combined with tamoxifen in postmenopausal early breast cancer compared with tamoxifen or placebo – Meta-analyses on efficacy and adverse events based on randomized clinical trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.